SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023)

SS Innovations International (SSII) reported Income from Non-Controlling Interests of -$1.9 million for Q3 2023, down 725.1% on a YoY basis from $303717.0 in Q3 2022, and down 76.68% sequentially from -$1.1 million in Q2 2023.

SS Innovations International (SSII) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

SS Innovations International (SSII) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$1.9 million in Q3 2023.

  • For the quarter ending Q3 2023, Income from Non-Controlling Interests fell 725.1% year-over-year to -$1.9 million; the trailing twelve-month figure through Sep 2023 stood at -$3.3 million (changed N/A YoY), and the FY2021 full-year result was -$352.0, changed N/A from the prior year.
  • Income from Non-Controlling Interests retreated to -$1.9 million in Q3 2023, from -$1.1 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $303717.0 in Q3 2022 to a low of -$1.9 million in Q3 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 183.58 Bn 176.28 Bn 6.27 Bn -
2 Stryker 129.01 Bn 126.13 Bn 3.81 Bn -
3 Medtronic 108.52 Bn 99.30 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 68.67 Bn 67.22 Bn 3.61 Bn -2.00 Mn
5 Edwards Lifesciences 48.33 Bn 44.66 Bn 1.29 Bn -
6 Dexcom 28.34 Bn 27.23 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.07 Bn 25.79 Bn 1.98 Bn 22.00 Mn
8 Smith & Nephew 26.89 Bn 26.31 Bn - -
9 Koninklijke Philips 24.12 Bn 21.00 Bn 2.07 Bn -5.85 Mn
10 SS Innovations International 770.31 Mn 746.70 Mn 5.33 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 -1.90 Mn
Jun 30, 2023 -1.07 Mn
Sep 30, 2022 303,717.00
Jun 30, 2022 -582,023.00